• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: PD

Uric acid and Parkinson’s disease

April 10, 2013  

Tremor- vs. non-tremor-dominant PD: fMRI findings

March 13, 2013  

GDS recommended for depression screening in PD

November 21, 2012  

Dopamine agonist withdrawal syndrome: Canadian study results

October 24, 2012  

Small, short-term benefit with physiotherapy in PD: meta-analysis

October 24, 2012  

Medication problems when PD patients admitted to hospital

August 21, 2012  

Exploring gene-environment interactions in PD

July 25, 2012  

Exploratory study of higher carbidopa dosing

July 11, 2012  

Tai chi improves balance impairments in PD

June 6, 2012  

Treatment of non-motor symptoms of PD: MDS recommendations

May 2, 2012  
Previous
1
2
3
4
5
Next

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Ultomiris (ravulizumab) now publicly reimbursed in gMG posted on April 7, 2026
  • Ofatumumab – new data on efficacy and safety posted on April 14, 2025
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions